Highlights and Quick Summary
- EPS (Diluted, Consolidated) for the quarter ending June 30, 2023 was $-0.456 (a -8.89% decrease compared to previous quarter)
- Year-over-year quarterly EPS (Diluted, Consolidated) increased by 320.46%
- Annual EPS (Diluted, Consolidated) for 2022 was $-1.55 (a -3.73% decrease from previous year)
- Annual EPS (Diluted, Consolidated) for 2021 was $-1.61 (a 5418.49% increase from previous year)
- Annual EPS (Diluted, Consolidated) for 2020 was $-0.0292 (a -97.47% decrease from previous year)
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS (Diluted, Consolidated) of DURECT Corporation
Most recent EPS (Diluted, Consolidated)of DRRX including historical data for past 10 years.Interactive Chart of EPS (Diluted, Consolidated) of DURECT Corporation
DURECT Corporation EPS (Diluted, Consolidated) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $0.0 | $0.0 | – | – | – |
| 2022 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2021 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2020 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2019 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2018 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2017 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2016 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2015 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2014 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2013 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2012 | $0.0 | $0.0 | – | – | $0.0 |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic